/CURLF

CURLF Stock - Curaleaf Holdings, Inc.

Q: What is the analyst price target for CURLF?

Analyst price target information is not currently available for CURLF.

Q: What is CURLF's market cap?

Market capitalization information is not currently available for CURLF.

Healthcare|Drug Manufacturers - Specialty & Generic|OTC

$2.63-3.31%

$0.09 (-3.31%) • Jan 13

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

BUY

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

100

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+405.3%upside

Target: $13.29

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for CURLF

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta1.47

52W High$5.05

52W Low$0.68

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$1.28B	$1.37B	$1.22B	$1.19B	$659.74M
Gross Profit	$444.98M	$486.43M	$492.56M	$480.43M	$111.58M
Gross Margin	34.8%	35.5%	40.2%	40.5%	16.9%
Operating Income	$19.23M	$43.67M	$62.41M	$58.06M	$-160,211,790
Net Income	$-226,733,626	$-286,353,819	$-355,434,685	$-204,127,936	$-60,180,624
Net Margin	-17.7%	-20.9%	-29.0%	-17.2%	-9.1%
EPS	$-0.29	$-0.40	$-0.53	$-0.16	$-0.11

Company Overview

Curaleaf Holdings, Inc. operates a cannabis operator in the United States. It operates in two segments, Cannabis Operations and Non-Cannabis Operations. The Cannabis Operations segment engages in the production and sale of cannabis through retail and wholesale channels. The Non-Cannabis Operations segment provides professional services, including cultivation, processing, and retail know-how and back-office administration, intellectual property licensing, real estate leasing services, and lending facilities to medical and adult-use cannabis licensees under management service agreements. It offers flowers, pre-rolls, flower pods, and dry-herb vaporizer cartridges; concentrates for vaporizing, such as pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, including distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. The company also provides hemp-based CBD products. As of June 16, 2022, it operated 134 dispensaries and 26 cultivation sites in 22 states of the United States. The company was founded in 2010 and is headquartered in Wakefield, Massachusetts.

Visit Website

Earnings History & Surprises

CURLF

Beat Rate

19%

Last 16 quarters

Avg Surprise

-89.2%

EPS vs Estimate

Beats / Misses

3/12

1 met exactly

Latest EPS

$-0.06

Q4 2025

EPS Surprise History

Q1 24

-50.0%

$-0.09vs$-0.06

Q2 24

-16.7%

$-0.07vs$-0.06

Q3 24

-20.0%

$-0.06vs$-0.05

Q4 24

-16.7%

$-0.07vs$-0.06

Q1 25

+133.3%

$0.02vs$-0.06

Q2 25

0.0%

$-0.07vs$-0.07

Q3 25

+14.3%

$-0.06vs$-0.07

Q4 25

+14.3%

$-0.06vs$-0.07

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q2 2026	May 6, 2026	—	—	—	—
Q1 2026	Mar 2, 2026	$-0.08	—	—	—
Q4 2025	Nov 5, 2025	$-0.07	$-0.06	+14.3%	✓ BEAT
Q3 2025	Aug 6, 2025	$-0.07	$-0.06	+14.3%	✓ BEAT
Q2 2025	May 8, 2025	$-0.07	$-0.07	0.0%	= MET
Q1 2025	Mar 3, 2025	$-0.06	$0.02	+133.3%	✓ BEAT
Q4 2024	Nov 6, 2024	$-0.06	$-0.07	-16.7%	✗ MISS
Q3 2024	Aug 7, 2024	$-0.05	$-0.06	-20.0%	✗ MISS
Q2 2024	May 9, 2024	$-0.06	$-0.07	-16.7%	✗ MISS
Q1 2024	Mar 6, 2024	$-0.06	$-0.09	-50.0%	✗ MISS
Q4 2023	Nov 9, 2023	$-0.06	$-0.09	-50.0%	✗ MISS
Q3 2023	Aug 9, 2023	$-0.03	$-0.07	-136.9%	✗ MISS
Q2 2023	May 1, 2023	$-0.05	$-0.23	-360.0%	✗ MISS
Q1 2023	Mar 28, 2023	$-0.04	$-0.38	-850.9%	✗ MISS
Q4 2022	Nov 7, 2022	$-0.05	$-0.07	-40.0%	✗ MISS
Q3 2022	Aug 8, 2022	$-0.04	$-0.04	-2.6%	✗ MISS
Q2 2022	May 9, 2022	$-0.02	$-0.03	-25.0%	✗ MISS
Q1 2022	Mar 3, 2022	$-0.03	$-0.04	-20.0%	✗ MISS
Q4 2021	Nov 8, 2021	—	$-0.08	—	—
Q3 2021	Aug 9, 2021	—	$-0.01	—	—

Frequently Asked Questions about CURLF

What is CURLF's current stock price?

Curaleaf Holdings, Inc. (CURLF) is currently trading at $2.63 per share. The stock has moved -3.31% today.

What is the analyst price target for CURLF?

The average analyst price target for CURLF is $13.29, based on 1 analyst.

What sector is Curaleaf Holdings, Inc. in?

Curaleaf Holdings, Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.

What is CURLF's market cap?

Curaleaf Holdings, Inc. has a market capitalization of $1.99 billion, making it a small-cap company.

Does CURLF pay dividends?

No, Curaleaf Holdings, Inc. does not currently pay a dividend to shareholders.